Critics said the researchers looked only at data in one state, limited the study period to 100 days post-injection, and failed to use appropriate search terms for finding possible cases of cardiac death related to COVID vaccination.
The negotiations, which began earlier this year and progressed to an exclusivity agreement in October, were expected to value BVNK between $1.5 billion and $2.5 billion....